<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00711737</url>
  </required_header>
  <id_info>
    <org_study_id>2008.06</org_study_id>
    <nct_id>NCT00711737</nct_id>
  </id_info>
  <brief_title>Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months</brief_title>
  <official_title>Open-label Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changi General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changi General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to explore the changes in metabolic parameters in patients
      treated with escitalopram for six months for major depression, generalized anxiety disorder
      or panic disorder, with or without agoraphobia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an open-label study, with 4 scheduled visits. Recruitment of 100 subjects.
      Assessments include demographics, diagnosis, smoking frequency, Clinical Global Scale
      (CGI-S), weight, height,blood pressure, waist and hip circumference and fasting blood glucose
      and lipd profile.

      Statistical analysis will be exploratory and mainly descriptive.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">27</enrollment>
  <condition>Major Depression</condition>
  <condition>Generalized Anxiety Disorder</condition>
  <condition>Panic Disorder</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients in psychiatric clinic in a general hosptial
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Give informed consent

          -  Requires pharmacological treatment with escitalopram for major depression, generalized
             anxiety disorder or panic disorder

          -  Aged 21 years old and above

          -  Able to comprehend and comply with protocol

          -  Not pregnant and if of child-bearing age, using adequate methods of contraception

        Exclusion Criteria:

          -  Currently taking or has taken in previous 3 months, any other antidepressants,
             antipsychotics, mood stabilizers, weight loss or lipid-profile modifying drugs

          -  Contraindications to escitalopram

          -  Unstable medical illness and/or is already under treatment of diabetes, hypertension,
             dyslipidemia, ischemic heart disease

          -  History of non-response to escitalopram

          -  Meets IDF definition of metabolic syndrome

          -  Significant risk of suicide

          -  Primary diagnosis or comorbid diagnosis of psychotic disorder, bipolar disorder,
             substance dependence and/or dementia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lai H Peh, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changi General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Changi General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>529889</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2008</study_first_submitted>
  <study_first_submitted_qc>July 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2008</study_first_posted>
  <last_update_submitted>June 15, 2011</last_update_submitted>
  <last_update_submitted_qc>June 15, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>Changi General Hospital</name_title>
    <organization>Changi General Hospital</organization>
  </responsible_party>
  <keyword>metabolic parameters</keyword>
  <keyword>escitalopram</keyword>
  <keyword>metabolic syndrome</keyword>
  <keyword>antidepressant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
    <mesh_term>Panic Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citalopram</mesh_term>
    <mesh_term>Dexetimide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

